NEOCATH 1000 W/HEPCOTE

FDA 510(k)

FDA Class 2 ·Anesthesiology

SPEACELABS MULTIGAS MODULE

FDA 510(k)

FDA Class 2 ·Anesthesiology

UMBILICAL ARTERY OXYGEN PROBE MODEL UAP-100

FDA 510(k)

FDA Class 2 ·Anesthesiology

SPACELABS MEDICAL MULTIGAS ANALYZER MODULE 91518 AND ACCESSORIES

FDA 510(k)

FDA Class 2 ·Anesthesiology

CONTINUCATH

FDA 510(k)

FDA Class 2 ·Anesthesiology

BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

INTRAVASCULAR BLOOD GAS SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

UMBILICAL ARTERY OXYGEN SENSOR

FDA 510(k)

FDA Class 2 ·Anesthesiology

OXYGEN MONITOR OM-100 & OXYGEN PROBE OP-100

FDA 510(k)

FDA Class 2 ·Anesthesiology

SPACELABS MEDICAL MULTIGAS ANALYZER

FDA 510(k)

FDA Class 2 ·Anesthesiology

VIA 1-01 INFUSION PUMP/BLOOD CHEMISTRY SYSTEM

FDA 510(k)

FDA Class 2 ·Anesthesiology

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·ACCESS HYBRITECH PSA REAGENTS ACCESS IMMUNOASSAY SYSTEMS

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·ACCESS HYBRITECH PSA ON THE SYNCHRON LXI 725 SYSTEM

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·TANDEM-MP PSA IMMUNOENZYMETRIC ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·HYBRITECH(R) STRATUS(R) PSA ASSAY FLOUROMETRIC

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval

FDA Class 2 ·ACCESS HYBRITECH PSA ON THE ACCESS 2 IMMUNOASSAY ANALYZER